Form 4 for ARWR ARROWHEAD PHARMACEUTICALS, INC.
Accepted 2024-12-20 00:00:00 ET · period of report 2024-12-18 · accession 0001628280-24-052271 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-20 | 2024-12-18 | ARWR | Waddill William D. | Dir | A - Grant | $22.99 | +16.7K | 57.1K | +41% | +$384.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-18 | A | A | 16,733 | $22.99 | 57,111 | D | — | — | (F1) Represents shares underlying restricted stock units, which shares will vest in one installment on the first anniversary date. |